Financial Statements — USAR
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Cash & Equivalents | 1.53 | 1.75 | 0.26 | 0.12 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventory | 0.05 | 0.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 1.67 | 1.79 | 0.26 | 0.12 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Property, Plant & Equipment | 0.15 | 0.12 | 0.04 | 0.03 | 0.00 | -- | -- | -- | -- | -- | -- |
| Goodwill | 0.13 | 0.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | 0.07 | 0.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 1.33 | 0.34 | 0.06 | 0.06 | 0.05 | 0.27 | 0.27 | 0.26 | 0.26 | 0.25 | -- |
| Total Assets | 3.00 | 2.13 | 0.32 | 0.18 | 0.08 | 0.27 | 0.27 | 0.26 | 0.26 | 0.25 | 0.00 |
| Accounts Payable | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- |
| Total Current Liabilities | 0.05 | 0.05 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-current Liabilities* | 0.40 | 0.20 | 0.35 | 0.28 | 0.09 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Total Liabilities* | 0.45 | 0.25 | 0.37 | 0.29 | 0.10 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Retained Earnings | (0.46) | (0.45) | (0.34) | (0.18) | (0.04) | (0.02) | (0.01) | (0.01) | (0.01) | (0.01) | -0.00 |
| Total Stockholder Equity* | 2.55 | 1.89 | (0.05) | (0.11) | (0.02) | (0.02) | (0.01) | (0.01) | (0.01) | (0.01) | 0.00 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Total Revenue | 5.82 | 5.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | 7.40 | 5.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | (1.58) | 0.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 10.77 | 14.25 | 7.17 | 4.45 | 2.58 | 1.69 | -- | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | 32.61 | 21.18 | 18.47 | 11.41 | 6.23 | 7.03 | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.73 | 36.78 | -- | -- | 17.52 | -- | -- | -- | -- | -- | -- | -- | 0.01 |
| Operating Income | (46.31) | (36.67) | (26.12) | (15.86) | (8.80) | (8.72) | (1.38) | (1.92) | (0.35) | (0.43) | (0.42) | (0.23) | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | 0.10 |
| Pretax Income | (12.48) | (68.64) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Tax Provision | (0.51) | (0.58) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (10.33) | (66.99) | (50.20) | (156.68) | (142.51) | 51.83 | 0.42 | 1.51 | 3.04 | 2.92 | 2.86 | 0.83 | (0.01) |
| Basic EPS | (0.05) | (0.34) | (0.88) | (1.64) | (1.54) | 0.75 | -- | -- | -- | -- | -- | -- | 0.00 |
| Diluted EPS | (0.05) | (0.34) | (0.71) | (1.64) | (1.54) | 0.58 | -- | -- | -- | -- | -- | -- | 0.00 |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 |
|---|
| Operating Cash Flow | (0.06) | (0.02) | (0.03) | -0.00 | (0.01) | (0.01) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Capital Expenditures | 0.07 | 0.04 | 0.02 | 0.01 | 0.01 | 0.00 | -- | -- | -- | -- | -- | -- |
| Free Cash Flow* | (0.13) | (0.06) | (0.05) | (0.01) | (0.01) | (0.01) | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | (0.07) | (0.04) | (0.13) | (0.01) | -0.00 | -0.00 | -- | -- | -- | -- | 0.00 | (0.25) |
| Financing Cash Flow | (0.03) | 1.45 | 0.26 | 0.15 | 0.11 | 0.02 | (0.25) | 0.00 | -- | -- | 0.00 | 0.25 |
* Derived from reported values
